Major depressive disorder affects tens of millions of people each year. One-third of those affected have depression that is resistant to conventional pharmacologic, psychologic, or somatic treatments. Patients with treatment-resistant depression have few remedies other than electroconvulsive therapy or transcranial magnetic stimulation. Recent research has highlighted the promising antidepressant effects of subanesthetic ketamine infusions Chicago. A recent study evaluated combining ketamine infusions with ECT.
134 patients diagnosed with Major Depressive Disorder were randomized to receive ECT with or without ketamine infusions. The level of depression was assessed at the 1 and 3 month intervals. The study results indicated that ketamine-assisted ECT achieved a higher remission rate (P < 0.05). In conclusion, intermittent administration of low dose ketamine in ECT significantly improved the effects of ECT and decreased psychiatric complications.
We are a ketamine clinic that administers ketamine infusions for patients with severe treatment resistant depression. Our mission is to make this important new treatment accessible to everyone that needs it.
